SCHEMBL19207465

SCHEMBL19207465

O=C(NCc1ccccn1)c1cc[nH]n1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.58
RAB9A P51151 2/20 0.55
KMT2A Q03164 2/20 0.55
MAPK1 P28482 2/20 0.55
KDM4E B2RXH2 2/20 0.55
HSD17B10 Q99714 2/20 0.55
MAPK10 P53779 1/20 0.55
HPGD P15428 4/20 0.55
ALDH1A1 P00352 3/20 0.55
POLB P06746 2/20 0.55
LMNA P02545 2/20 0.55
NPC1 O15118 1/20 0.55
MEN1 O00255 1/20 0.54
MAPK14 Q16539 1/20 0.54
GLS O94925 1/20 0.53
ADORA2A P29274 1/20 0.53
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8722201 0.82 SMN1; SMN2 (0.69) SMN1; SMN2RAB9AKMT2AMAPK1KDM4E
SCHEMBL4288847 0.79 MMP13 (0.58) SMN1; SMN2KMT2AHPGDALDH1A1
SCHEMBL20610606 0.76 HPGD (0.60) SMN1; SMN2RAB9AKMT2AMAPK1KDM4E
SCHEMBL4174785 0.75 SMN1; SMN2 (0.59) SMN1; SMN2RAB9AKMT2AMAPK1KDM4E
SCHEMBL166484 0.75 LMNA (0.82) SMN1; SMN2RAB9AKMT2AKDM4EHSD17B10
SCHEMBL22600769 0.75 ALDH1A1 (0.48) RAB9AHPGDALDH1A1POLBNPC1
SCHEMBL1198985 0.75 NPC1 (0.58) SMN1; SMN2RAB9AKMT2AKDM4EALDH1A1
SCHEMBL21065524 0.74 SMN1; SMN2 (0.79) SMN1; SMN2RAB9AKMT2AKDM4EALDH1A1
SCHEMBL29460273 0.74 SMN1; SMN2 (0.79) SMN1; SMN2RAB9AKMT2AKDM4EALDH1A1
SCHEMBL30522589 0.74 SMN1; SMN2 (1.00) SMN1; SMN2RAB9AKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed